Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,411 | -26,443 | 56,823 | 79,490 | -19,370 |
| Depreciation Amortization | 1,700 | 854 | 2,371 | 1,659 | 1,040 |
| Other Working Capital | 2,478 | -594 | -98,932 | -100,023 | -31,201 |
| Other Operating Activity | 5,257 | 2,637 | 9,609 | 7,344 | 5,055 |
| Operating Cash Flow | $-44,976 | $-23,546 | $-30,129 | $-11,530 | $-44,476 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -30,752 | -19,856 | -188,999 | -147,995 | -89,480 |
| PPE Investments | -50 | -50 | -985 | -985 | -562 |
| Sale Of Investment | 95,387 | 63,650 | 221,366 | 178,661 | 124,508 |
| Investing Cash Flow | $64,585 | $43,744 | $31,382 | $29,681 | $34,466 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,613 | 1,552 | 4,082 | 345 | 98 |
| Financing Cash Flow | $1,613 | $1,552 | $4,082 | $345 | $98 |
| Beginning Cash Position | 54,511 | 54,511 | 49,176 | 49,176 | 49,176 |
| End Cash Position | 75,733 | 76,261 | 54,511 | 67,672 | 39,264 |
| Net Cash Flow | $21,222 | $21,750 | $5,335 | $18,496 | $-9,912 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,976 | -23,546 | -30,129 | -11,530 | -44,476 |
| Capital Expenditure | -50 | -50 | -985 | -985 | -562 |
| Free Cash Flow | -45,026 | -23,596 | -31,114 | -12,515 | -45,038 |